This conversation focuses largely on system preparedness and ways to improve scanners and other screening devices. One key point: this becomes more feasible now that Rezdiffra has been approved.
Jeff Lazarus describes the meeting agenda and some of the anticipated outputs, after which other panelists discuss the broad range of issues this design produced.
SLD Think Tank 2023 co-chairs Jörn Schattenberg and Jeff Lazarus and participants Maja Thiele and Mike Betel join Louise Campbell and Roger Green to discuss high points of the recent Barcelona meting.
Colleagues and friends Manal Abdelmalek and Naim Alkhouri join the Surfers in the first of what will be several conversations remembering our co-founder, the SLD master Stephen Harrison.
This closing conversation centers first around Roger’s use of the “blind people touching an elephant” metaphor to describe the complexity of MASH, and then creates a second goal, this time for providers to “rule out the liver.”
The group, including co-hosts Louise Campbell and Roger Green along with guests Jeff McIntyre and Mike Betel, dives deeper into the care challenges and barriers confronting MASH patient care today.
Global Liver Institute Vice President of Liver Programs Jeff McIntyre describes the rational behind GLI’s 2024 theme, after which Mike Betel and Roger Green share reactions.
Patient advocates Jeff McIntyre (Global Liver Institute) and Mike Betel (Fatty Liver Alliance, Liver Action Network) join Louise Campbell and Roger Green to discuss GLI’s premier MASH patient event, now known as Global Fatty Livery Day.
Sven Francque and William Alazawi join the Surfers discuss the impact of concomitant metabolic therapies like incretin agonists on MASH Drug Development.
Sven Francque and William Alazawi join the Surfers to to consider how we have translated the lessons of previous failed trials into better designs that produce successful trials.
